Cancer Genetics, Inc. [CGIX] to Ring The NASDAQ Stock Market Opening Bell
August 27 2013 - 10:00AM
ADVISORY, Aug. 27, 2013 (GLOBE NEWSWIRE) --
What:
Cancer Genetics, Inc. [CGIX], an emerging leader in DNA-based
cancer diagnostics that personalizes the diagnosis and prediction
of treatment outcomes for difficult to diagnose cancers, will visit
the NASDAQ MarketSite in Times Square.
In honor of the occasion, Raju Chaganti,
Chairman, Panna Sharma, CEO, and others
from the Cancer Genetics senior management team will ring the
Opening Bell.
Where:
NASDAQ MarketSite – 4 Times Square – 43rd & Broadway –
Broadcast Studio
When:
Wednesday, August 28, 2013 – 9:15 a.m. to 9:30 a.m. ET
Contact: Panna Sharma (201) 528-9200
psharma@cancergenetics.com
NASDAQ MarketSite: Christine Barna (646)
441-5310 Christine.Barna@nasdaqomx.com
Feed Information:
Fiber Line (Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC
3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Facebook and Twitter:
For multimedia features such as exclusive content, photo
postings, status updates and video of bell ceremonies please visit
our Facebook page at:
http://www.facebook.com/NASDAQ.
For news tweets, please visit our Twitter page at:
http://twitter.com/nasdaqomx.
Webcast:
A live webcast of the NASDAQ Opening Bell will be available at:
http://www.nasdaq.com/about/marketsitetowervideo.asx.
Photos:
To obtain a hi-resolution photograph of the Market Open, please
go to http://www.nasdaq.com/reference/marketsite_events.stm and
click on the market open of your choice.
About Cancer Genetics, Inc.
[CGIX]:
Cancer Genetics, Inc. is an emerging leader in DNA-based cancer
diagnostics that personalizes the diagnosis and prediction of
treatment outcomes for difficult to diagnose cancers. These cancers
include hematological, urogenital and HPV-associated cancers. The
Company's comprehensive range of oncology-focused tests and
laboratory services provide critical genomic information to
healthcare professionals, cancer centers, and to biopharma
companies. Through its CLIA certified and CAP accredited
state-of-the-art reference lab, Cancer Genetics services some
of the most prestigious medical institutions in the world and has
strong research collaborations with major cancer centers such as
Memorial Sloan-Kettering, The Cleveland Clinic, Mayo Clinic and the
National Cancer Institute. For further information, please
see www.cancergenetics.com.
About NASDAQ OMX Group:
The inventor of the electronic exchange, The NASDAQ OMX Group,
Inc., fuels economies and provides transformative technologies for
the entire lifecycle of a trade - from risk management to trade to
surveillance to clearing. In the U.S. and Europe, we own and
operate 26 markets including 3 clearinghouses and 5 central
securities depositories supporting equities, options, fixed income,
derivatives, commodities, futures and structured products. Able to
process more than 1 million messages per second at sub-55
microsecond average speeds with 99.99% uptime, our technology
drives more than 70 marketplaces in 50 developed and emerging
countries into the future, powering 1 in 10 of the world's
securities transactions. Our award-winning data products and
worldwide indexes are the benchmarks in the financial industry.
Home to approximately 3,300 listed companies worth $6 trillion in
market cap whose innovations shape our world, we give the ideas of
tomorrow access to capital today. Welcome to where the world takes
a big leap forward, daily. Welcome to the NASDAQ OMX Century. To
learn more, visit www.nasdaqomx.com. Follow us on Facebook
(http://www.facebook.com/NASDAQ) and Twitter
(http://www.twitter.com/nasdaqomx). (Symbol: NDAQ and member of
S&P 500)
-NDAQA-
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Apr 2024 to May 2024
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From May 2023 to May 2024